EyePoint Inc（EYPT）价格预测

$0.405

-0.022 (-5.51%)收盘时

价格预测

1-Day Price Prediction

+0.36%

1-Week Prediction

+0.56%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中打开以解锁更长周期的预测。

Loading chart…

EYPT 相似图表分析预测

Alphio's EYPT stock price prediction model matches the current EyePoint Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.41 (+0.36%). The 1-week path is $0.41 (+0.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 EyePoint Inc 股票吗？

EyePoint Pharmaceuticals is not a good buy right now due to its current price of $0.4045, which reflects an 80% drop following the failure of its Phase 3 LUCIA trial. The RSI is extremely low at 7.065, indicating oversold conditions, but the company's fundamentals are deteriorating with a forward P/E of 6.1614 and a net income loss of -94,470,000 USD in Q2 2026. The main risk is the significant uncertainty surrounding its regulatory path and future trials, which could further impact its stock price negatively.

EYPT 股价于 Friday 收于 $0.40，此前下跌 -5.51%

EyePoint Inc (EYPT) last closed at $0.4045, losing -5.51%. These facts feed the 1-day and 1-week EYPT price prediction above.

预测驱动因素

EyePoint Inc（EYPT）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 EYPT 最接近的股票，按相似度排序。

PSN

94.13%

-26.19%

SITC

94.02%

+1.96%

UWMC

93.09%

-11.26%

OPCH

92.82%

-1.86%

LUMN

92.16%

-3.04%

EYPT 季节性分析

Historically the probability of a positive October return for EYPT is 36.51%. December offers the highest probability of a positive month at 51.16%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…